Vrna23 Dec 2021 15:38
Hi Rhodi, good to see that you are still in touch with Vrna with a bit of a stake!
I still have my original stake, albeit heavily diluted, but still enough to keep a keen eye on progress.
The recent cardiac results were good and no doubt required by the FDA. I also remember there were cases in an earlier trial, with an
Increase in heart rate, so it’s good that is not deemed to be problem. I am also very happy that the P3 end point targets are based on FEV and general improvement in well being. FEV has always been good in every previous trial, so I personally believe that the prospects for success are good, and on that basis, I look forward to 2022.
I wish you and Izstar all the best for Xmas and hope we can meet under better circumstances next year.